• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一名儿童高级别胶质瘤幸存者中发现新型GOPC(FIG)-ROS1融合基因。

Novel GOPC(FIG)-ROS1 fusion in a pediatric high-grade glioma survivor.

作者信息

Kiehna Erin N, Arnush Maxine R, Tamrazi Benita, Cotter Jennifer A, Hawes Debra, Robison Nathan J, Fong Cindy Y, Estrine Dolores B, Han Jennifer H, Biegel Jaclyn A

机构信息

Departments of 1 Neurosurgery.

University of California, Berkeley, California.

出版信息

J Neurosurg Pediatr. 2017 Jul;20(1):51-55. doi: 10.3171/2017.2.PEDS16679. Epub 2017 Apr 7.

DOI:10.3171/2017.2.PEDS16679
PMID:28387643
Abstract

Pediatric high-grade glioma is a rare tumor characterized by high mortality. The authors report the first case of a high-grade glioma associated with a GOPC(FIG)-ROS1 fusion in a pediatric patient. The patient underwent gross-total resection at the age of 4 years, followed by adjuvant high-dose chemotherapy and autologous hematopoietic stem cell rescue. At 30 months after transplantation, she remains disease free.

摘要

小儿高级别胶质瘤是一种死亡率很高的罕见肿瘤。作者报告了首例小儿患者中与GOPC(FIG)-ROS1融合相关的高级别胶质瘤病例。该患者4岁时接受了肿瘤全切除,随后进行辅助大剂量化疗及自体造血干细胞挽救治疗。移植后30个月,她仍无疾病复发。

相似文献

1
Novel GOPC(FIG)-ROS1 fusion in a pediatric high-grade glioma survivor.一名儿童高级别胶质瘤幸存者中发现新型GOPC(FIG)-ROS1融合基因。
J Neurosurg Pediatr. 2017 Jul;20(1):51-55. doi: 10.3171/2017.2.PEDS16679. Epub 2017 Apr 7.
2
GOPC-ROS1 Fusion Due to Microdeletion at 6q22 Is an Oncogenic Driver in a Subset of Pediatric Gliomas and Glioneuronal Tumors.6q22 微缺失导致的 GOPC-ROS1 融合是一组儿童神经胶质瘤和神经胶质神经元肿瘤的致癌驱动基因。
J Neuropathol Exp Neurol. 2019 Dec 1;78(12):1089-1099. doi: 10.1093/jnen/nlz093.
3
Identification of a novel KLC1-ROS1 fusion in a case of pediatric low-grade localized glioma.鉴定一例儿童低级别局限性神经胶质瘤中的新型 KLC1-ROS1 融合。
Brain Tumor Pathol. 2019 Jan;36(1):14-19. doi: 10.1007/s10014-018-0330-3. Epub 2018 Oct 22.
4
Lack of GOPC-ROS1 (FIG-ROS1) rearrangement in adult human gliomas.成人胶质瘤中缺乏GOPC-ROS1(FIG-ROS1)重排。
Eur J Cancer. 2014 Sep;50(13):2364-6. doi: 10.1016/j.ejca.2014.06.001. Epub 2014 Jul 3.
5
GOPC:ROS1 and other ROS1 fusions represent a rare but recurrent drug target in a variety of glioma types.GOPC:ROS1及其他ROS1融合基因在多种类型的胶质瘤中是一种罕见但反复出现的药物靶点。
Acta Neuropathol. 2021 Dec;142(6):1065-1069. doi: 10.1007/s00401-021-02369-1. Epub 2021 Sep 18.
6
Rare but Recurrent ROS1 Fusions Resulting From Chromosome 6q22 Microdeletions are Targetable Oncogenes in Glioma.罕见但反复出现的 ROS1 融合是由染色体 6q22 微缺失引起的,是神经胶质瘤的可靶向致癌基因。
Clin Cancer Res. 2018 Dec 15;24(24):6471-6482. doi: 10.1158/1078-0432.CCR-18-1052. Epub 2018 Aug 31.
7
ROS1 Alterations as a Potential Driver of Gliomas in Infant, Pediatric, and Adult Patients.ROS1 改变作为婴儿、儿童和成年患者神经胶质瘤的潜在驱动因素。
Mod Pathol. 2023 Nov;36(11):100294. doi: 10.1016/j.modpat.2023.100294. Epub 2023 Jul 31.
8
Oncogenic GOPC-ROS1 Fusion Identified in a Congenital Glioblastoma Case.先天性脑胶质瘤中发现致癌性 GOPC-ROS1 融合。
J Pediatr Hematol Oncol. 2020 Nov;42(8):e813-e818. doi: 10.1097/MPH.0000000000001711.
9
Novel Fusion Gene Activates MAPK, PI3K and JAK/STAT Signaling in an Infant-type Pediatric Glioma.新型融合基因在婴儿型小儿脑胶质瘤中激活 MAPK、PI3K 和 JAK/STAT 信号通路。
Cancer Genomics Proteomics. 2022 Nov-Dec;19(6):711-726. doi: 10.21873/cgp.20354.
10
[Infant-type hemispheric glioma with EEF1G-ROS1 fusion: report of a case].
Zhonghua Bing Li Xue Za Zhi. 2023 Apr 8;52(4):408-410. doi: 10.3760/cma.j.cn112151-20220715-00611.

引用本文的文献

1
The oncogenic fusion landscape in pediatric CNS neoplasms.小儿中枢神经系统肿瘤中的致癌融合景观。
Acta Neuropathol. 2022 Apr;143(4):427-451. doi: 10.1007/s00401-022-02405-8. Epub 2022 Feb 15.
2
Fusion Genes Altered in Adult Malignant Gliomas.成人恶性胶质瘤中发生改变的融合基因。
Front Neurol. 2021 Oct 4;12:715206. doi: 10.3389/fneur.2021.715206. eCollection 2021.
3
Profiling Receptor Tyrosine Kinase Fusions in Chinese Breast Cancers.中国乳腺癌中受体酪氨酸激酶融合基因的分析
Front Oncol. 2021 Sep 28;11:741142. doi: 10.3389/fonc.2021.741142. eCollection 2021.
4
Successful Treatment of Patients with Refractory High-Grade Serous Ovarian Cancer with GOPC-ROS1 Fusion Using Crizotinib: A Case Report.克唑替尼成功治疗携带 GOPC-ROS1 融合的难治性高级别浆液性卵巢癌:一例报告。
Oncologist. 2020 Nov;25(11):e1720-e1724. doi: 10.1634/theoncologist.2019-0609. Epub 2020 Jul 25.
5
Infant High-Grade Gliomas Comprise Multiple Subgroups Characterized by Novel Targetable Gene Fusions and Favorable Outcomes.婴儿高级别神经胶质瘤包含多个亚组,其特征为新型可靶向基因融合和良好的预后。
Cancer Discov. 2020 Jul;10(7):942-963. doi: 10.1158/2159-8290.CD-19-1030. Epub 2020 Apr 1.
6
Clinical management and genomic profiling of pediatric low-grade gliomas in Saudi Arabia.沙特阿拉伯儿科低级别胶质瘤的临床管理和基因组分析。
PLoS One. 2020 Jan 29;15(1):e0228356. doi: 10.1371/journal.pone.0228356. eCollection 2020.
7
Alterations in ALK/ROS1/NTRK/MET drive a group of infantile hemispheric gliomas.ALK/ROS1/NTRK/MET 改变驱动一组婴儿半球胶质瘤。
Nat Commun. 2019 Sep 25;10(1):4343. doi: 10.1038/s41467-019-12187-5.
8
Mechanisms of receptor tyrosine kinase activation in cancer.受体酪氨酸激酶在癌症中的激活机制。
Mol Cancer. 2018 Feb 19;17(1):58. doi: 10.1186/s12943-018-0782-4.